Similar articles

• Do not use bisphosphonate therapy indefinitely for fracture prevention.

  [No authors listed] [No authors listed] Prescrire Int. 2008 Oct;17(97):214. Prescrire Int. 2008. PMID: 19536944
• [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2004 May 20;146(21):63. MMW Fortschr Med. 2004. PMID: 15373093 German. No abstract available.
• [New knowledge on alendronate (Fosamax) and fractures].

  Kopjar B, Bjørndal A. Kopjar B, et al. Tidsskr Nor Laegeforen. 1999 Feb 20;119(5):702. Tidsskr Nor Laegeforen. 1999. PMID: 10095398 Norwegian. No abstract available.
• Clinical inquiries. What is the best approach to prevention and treatment of osteoporosis?

  Schwartz K, Chang SI. Schwartz K, et al. J Fam Pract. 2001 Dec;50(12):1024-5. J Fam Pract. 2001. PMID: 11742601 Review. No abstract available.
• Fracture prevention in postmenopausal women.

  Bruyere O, Reginster JY. Bruyere O, et al. Clin Evid. 2002 Jun;(7):979-82. Clin Evid. 2002. Update in: Clin Evid. 2002 Dec;(8):1089-102. PMID: 12230720 Updated. Review. No abstract available.